These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 19734400)

  • 1. A lifestyle intervention study in patients with diabetes or impaired glucose tolerance: translation of a research intervention into practice.
    Matvienko OA; Hoehns JD
    J Am Board Fam Med; 2009; 22(5):535-43. PubMed ID: 19734400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.
    Kramer MK; Kriska AM; Venditti EM; Miller RG; Brooks MM; Burke LE; Siminerio LM; Solano FX; Orchard TJ
    Am J Prev Med; 2009 Dec; 37(6):505-11. PubMed ID: 19944916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program.
    Amundson HA; Butcher MK; Gohdes D; Hall TO; Harwell TS; Helgerson SD; Vanderwood KK;
    Diabetes Educ; 2009; 35(2):209-10, 213-4, 216-20 passim. PubMed ID: 19321807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in cardiovascular disease risk factors: 6-month results from Project Active.
    Dunn AL; Marcus BH; Kampert JB; Garcia ME; Kohl HW; Blair SN
    Prev Med; 1997; 26(6):883-92. PubMed ID: 9388801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of type 2 diabetes in a primary health care setting. Interim results from the Greater Green Triangle (GGT) Diabetes Prevention Project.
    Kilkkinen A; Heistaro S; Laatikainen T; Janus E; Chapman A; Absetz P; Dunbar J
    Diabetes Res Clin Pract; 2007 Jun; 76(3):460-2. PubMed ID: 17069921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review.
    Norris SL; Zhang X; Avenell A; Gregg E; Bowman B; Schmid CH; Lau J
    Am J Prev Med; 2005 Jan; 28(1):126-39. PubMed ID: 15626569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
    Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
    Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance and impaired fasting glucose.
    Rao SS; Disraeli P; McGregor T
    Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes.
    Gagnon C; Brown C; Couture C; Kamga-Ngande CN; Hivert MF; Baillargeon JP; Carpentier AC; Langlois MF
    Diabetes Metab; 2011 Nov; 37(5):410-8. PubMed ID: 21489843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.
    Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG
    Diabetes Res Clin Pract; 2006 May; 72(2):117-27. PubMed ID: 16297488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DiabetAction: changes in physical activity practice, fitness, and metabolic syndrome in type 2 diabetic and at-risk individuals.
    Mathieu ME; Brochu M; Béliveau L
    Clin J Sport Med; 2008 Jan; 18(1):70-5. PubMed ID: 18185042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
    Soja AM; Zwisler AD; Frederiksen M; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Am Heart J; 2007 Apr; 153(4):621-8. PubMed ID: 17383302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.